Insmed (NASDAQ: INSM) director sells 5,000 shares via Padonia LLC
Rhea-AI Filing Summary
INSMED Inc (INSM) director Melvin Sharoky, MD reported an indirect sale of 5,000 shares of common stock on 2026-08-17 through Padonia, LLC at a weighted average price of $127.53 per share, within a range of $127.51–$127.61. After this transaction Padonia, LLC held zero shares. Dr. Sharoky continues to hold 246,081 shares directly, and additional shares are held indirectly through his spouse and several UTMA/FL custodial accounts for family members, for which he serves as custodian.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 5,000 shares
Net Sell
7 txns
Insider
SHAROKY MELVIN MD
Role
Director
Sold
5,000 shs ($638K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 5,000 | $127.53 | $638K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
| holding | Common Stock F5 | -- | -- | -- |
| holding | Common Stock F6 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Indirect, By Padonia, LLC);
Common Stock — 246,081 shares (Direct);
Common Stock — 6,847 shares (Indirect, By spouse);
Common Stock — 819 shares (Indirect, By Melvin Sharoky C/F Adler J. Wink UTMA/FL);
Common Stock — 5,423 shares (Indirect, By Melvin Sharoky C/F Nolan M. Wink UTMA/FL);
Common Stock — 5,007 shares (Indirect, By Melvin Sharoky C/F Sophie C. Wink UTMA/FL);
Common Stock — 3,724 shares (Indirect, By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL)
Footnotes (6)
- F1. This is the weighted average sales price representing 5,000 shares sold at prices ranging from $127.51 to $127.61 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F2. The Reporting Person is the managing member of Padonia, LLC.
- F3. The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.
- F4. The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.
- F5. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.
- F6. The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.
Key Figures
Shares sold: 5,000 shares
Weighted average sale price: $127.53 per share
Direct holdings after transaction: 246,081 shares
+5 more
8 metrics
Shares sold
5,000 shares
Indirect sale of INSM common stock by Padonia, LLC on 2026-08-17
Weighted average sale price
$127.53 per share
Weighted average price for 5,000 shares sold, within $127.51–$127.61 range
Direct holdings after transaction
246,081 shares
Common stock directly held by Melvin Sharoky, MD following reported transactions
Spouse indirect holdings
6,847 shares
INSM shares indirectly owned through spouse after transactions
UTMA/FL custodial account 1
819 shares
INSM shares held in UTMA/FL account for Adler J. Wink with Dr. Sharoky as custodian
UTMA/FL custodial account 2
5,423 shares
INSM shares held in UTMA/FL account for Nolan M. Wink with Dr. Sharoky as custodian
UTMA/FL custodial account 3
5,007 shares
INSM shares held in UTMA/FL account for Sophie C. Wink with Dr. Sharoky as custodian
UTMA/FL custodial account 4
3,724 shares
INSM shares held in UTMA/FL account for Tulia L. Sharoky with Dr. Sharoky as custodian
Key Terms
weighted average sales price, indirect ownership, UTMA/FL, Rule 10b5-1
4 terms
weighted average sales price financial
"This is the weighted average sales price representing 5,000 shares sold"
indirect ownership financial
"total_shares_following_transaction 0.0000, direct_or_indirect I, nature_of_ownership"
UTMA/FL financial
"Melvin Sharoky C/F Adler J. Wink UTMA/FL"
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction did INSM (INSMED Inc) disclose for Melvin Sharoky, MD?
INSM disclosed that director Melvin Sharoky, MD sold 5,000 shares of common stock on 2026-08-17 through Padonia, LLC. The sale was reported as an indirect transaction, with Padonia’s post-transaction balance in INSMED shares reported as zero.
Was the INSM insider sale by Padonia, LLC under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox was not marked as an affirmative plan election. No footnote describes the sale as made pursuant to a Rule 10b5-1 trading plan, so the transaction is not characterized there as pre-arranged under such a plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
